C07D 263/06
With hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
Official title: with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
C07D263/06 (With hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms) appears on 191 US grants and 137 published applications in this corpus.
Search patents in C07D- Granted patents
- 191
- Published applications
- 137
- Assignees
- 122
- Inventors
- 537
- Latest grant
- 19 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 9 | 0 |
| 1978 | 9 | 0 |
| 1979 | 6 | 0 |
| 1980 | 6 | 0 |
| 1981 | 12 | 0 |
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 3 | 0 |
| 1988 | 5 | 0 |
| 1989 | 5 | 0 |
| 1990 | 3 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 6 | 0 |
| 1994 | 4 | 0 |
| 1995 | 3 | 0 |
| 1996 | 4 | 0 |
| 1997 | 2 | 0 |
| 1998 | 0 | 0 |
| 1999 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 6 | 2 |
| 2002 | 2 | 9 |
| 2003 | 4 | 3 |
| 2004 | 5 | 10 |
| 2005 | 4 | 7 |
| 2006 | 7 | 6 |
| 2007 | 1 | 6 |
| 2008 | 2 | 6 |
| 2009 | 3 | 9 |
| 2010 | 8 | 12 |
| 2011 | 2 | 3 |
| 2012 | 5 | 6 |
| 2013 | 6 | 4 |
| 2014 | 1 | 6 |
| 2015 | 2 | 5 |
| 2016 | 5 | 6 |
| 2017 | 6 | 3 |
| 2018 | 3 | 4 |
| 2019 | 5 | 5 |
| 2020 | 5 | 9 |
| 2021 | 5 | 3 |
| 2022 | 0 | 2 |
| 2023 | 3 | 4 |
| 2024 | 1 | 2 |
| 2025 | 1 | 3 |
| 2026 | 2 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Broad spectrum anti-cancer compounds19 May 2026US 12,630,527 B2The Regents of the University of California
- Method of fixating carbon dioxide to substituted oxazolidinones31 Mar 2026US 12,590,074 B2King Fahd University of Petroleum and Minerals
- Oxazolidinone compounds and methods of use thereof as antibacterial agents22 Jul 2025US 12,365,656 B2Merck Sharp & Dohme Corp.
- Pro-benefit-agent compounds with heterocyclic moieties16 Jul 2024US 12,037,320 B2The Procter & Gamble Company
- Sphingosine kinase Type 1 inhibitors and uses thereof29 Aug 2023US 11,737,992 B2Enzo Therapeutics, Inc.
- Method for producing o-substituted serine derivative27 Aug 2026US 2026/0250241 A1Chugai Seiyaku Kabushiki Kaisha
- Novel inhibitors of dna damage responses for cancer therapy23 Jul 2026US 2026/0209193 A1The Regents of the University of California
- Method for preparing a reaction product, compositions including the reaction product, and uses of the reaction product5 Jun 2025US 2025/0179035 A1The Lubrizol Corporation
- Camptothecin derivative intermediate, and preparation method therefor and use thereof20 Feb 2025US 2025/0059143 A1Shanghai Best-Link Bioscience
- Cyclic acetals and ketals for the light-induced release of active aldehydes and ketones6 Feb 2025US 2025/0042871 A1Firmenich SA
Most cited
By later US patents
- Intermediates useful in the synthesis of optically active m-acyloxy-.alpha.-[(methylamino)methyl]benzyl alcohols64US 4,158,005 AINTERx Research Corporation · 1979
- Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance55US 6,693,099 B2The Procter & Gamble Company · 2004
- Inhibitors of glutaminyl cyclase53US 7,371,871 B2Probiodrug AG · 2008
- Herbicidal antidote compositions with substituted oxazolidines and thiazolidines34US 3,989,503 AStauffer Chemical Company · 1976
- Method of preparing sphingosine derivatives33US 5,110,987 AEmory University · 1992